Bioinfo Chem
Latest Issue - Volume 7 Number 1 2025
Discover the perfect home for your research. Our extensive collection of journals and sections spans over thousands academic disciplines, ensuring you find the right fit for your work.
Explore trending research themes and collaborate with leading experts. Join an existing community or start a new one to advance knowledge in emerging areas...
Begin your publishing journey with confidence. Access our comprehensive author hub for expert guidance, tools, and resources to help you prepare, submit, and share your research effectively.
Ready to make an impact? Submit your work today and amplify its reach by publishing with us. Start your submission process quickly and easily.
Benefit from our efficient peer review system. Receive timely decisions on your manuscript—our average acceptance time is just 76 days.
Bioinfo Chem
Bioinfo and Chem is an international, open access, peer-reviewed journal that publishes: Original Research; Reviews; Hypothesis formation and commentaries in the following fields Computational biomodelling, Bioinformatics, Computational genomics, Mol
Editorial board
See all >Volumes
See all (7) >Article
Bioinfo Chem
Volume 7 Number 1 2025
Table of Contents
Research Article
Computational Pharmacology
Shahadat Hossain1*, Farhana Ferdushi Aion2, Badhan Mojumder2
This study identifies Luteolin as a potential multi-target CDK4/6 inhibitor with broader anti-cancer action than current synthetic drugs.
Abstract | Full Text |PDF (692 KB) | Open Access Article
The peer-reviewed and edited version of record published online before inclusion in an issue
These articles have been peer reviewed and accepted for publication. They are still in production and have not been edited, so may differ from the final published form.
The Most Read ranking is based on the number of downloads in the last 60 days from papers published on the Bioinfo Chem within the last 12 months. Usage statistics are updated daily.
-
Harmine: A Natural β-Carboline with Promising Multi-Targeted Anticancer Potential
Harmine shows multi-targeted anticancer activity, offering potential as a natural, safer alternative to conventional chemotherapy for various cancers.
-
Network Pharmacology and Docking-Based Evaluation of Quercetin as an Inhibitor of PI3K Pathway in Glioblastoma
This study highlights quercetin’s multi-target inhibition of PI3K signaling in GBM, suggesting a safer, plant-based therapeutic alternative.
-
Virtual Screening and Computational Analysis of Natural Compound Targeting CDK4/6 for Pan-Cancer Therapeutic Potential
This study identifies Luteolin as a potential multi-target CDK4/6 inhibitor with broader anti-cancer action than current synthetic drugs.
-
Computational Elucidation of EGCG Interaction with PD-L1: A Natural Strategy for Immune Checkpoint Modulation in Melanoma
Epigallocatechin gallate (EGCG) offers a safe, natural alternative to antibody therapies by directly targeting PD-L1 and modulating immune response pathways.
-
Targeting Mutant KRAS G12C with Berberine Derivatives: A Molecular Docking and Dynamics Approach in Colorectal Cancer
Berberine offers a natural, safe, and multi-pathway alternative for selectively targeting KRAS G12C in colorectal cancer therapy development.
-
Artificial Intelligence in Drug Discovery: Systematic Review and Meta-Analysis of Predictive Performance, Structural Modeling, and Translational Reliability
This study demonstrates how AI improves prediction accuracy, accelerates drug discovery, reduces experimental burden, and enhances the reliability of therapeutic design workflows.
Submit Article
Use the online submission system to send us your manuscript.
Call for Papers
We are seeking Contributions for a special issue. More.
Best Paper Award
Authors are awarded for Best Paper for this Journal Annually
Advertisement